BIOA(BioAge Labs, Inc.) 的内部人交易:医疗保健,特药与仿制药。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 交易日 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-06-30 | Barton Shane | Principal Accounting Officer | 公开市场卖出 | 20,216 | $25.19 |
| 2026-06-29 | Barton Shane | Principal Accounting Officer | 公开市场卖出 | 42,350 | $25.21 |
| 2026-04-01 | RUBIN PAUL D | Chief Medical Officer | 公开市场卖出 | 8,820 | $17.81 |
| 2026-03-02 | RUBIN PAUL D | Chief Medical Officer | 公开市场卖出 | 7,433 | $20.30 |
| 2026-02-02 | RUBIN PAUL D | Chief Medical Officer | 公开市场卖出 | 7,433 | $18.75 |
| 2026-01-13 | Fortney Kristen | Chief Executive Officer | 公开市场卖出 | 233,107 | $18.12 |
| 2026-01-13 | GOLDSTEIN DOV A MD | Chief Financial Officer | 公开市场卖出 | 1,923 | $21.08 |
| 2026-01-13 | GOLDSTEIN DOV A MD | Chief Financial Officer | 公开市场卖出 | 11,663 | $20.54 |
| 2026-01-13 | GOLDSTEIN DOV A MD | Chief Financial Officer | 公开市场卖出 | 4,440 | $19.45 |
| 2026-01-13 | GOLDSTEIN DOV A MD | Chief Financial Officer | 公开市场卖出 | 8,974 | $18.43 |
| 2026-01-02 | RUBIN PAUL D | Chief Medical Officer | 公开市场卖出 | 7,433 | $12.85 |
| 2025-12-09 | RUBIN PAUL D | Chief Medical Officer | 公开市场卖出 | 18,000 | $12.00 |
| 2025-12-04 | RUBIN PAUL D | Chief Medical Officer | 公开市场卖出 | 68,897 | $10.19 |
| 2024-09-27 | Hemrajani Rekha | 董事 | 公开市场买入 | 3,000 | $18.00 |
| 2024-09-27 | Barton Shane | Principal Accounting Officer | 公开市场买入 | 2,632 | $18.00 |